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that the global cortical reductions in blood flow and me
tabolism correlatewith the extent of cognitive impairment
in AD (11,17,20â€”22)and this covariation may be most
strongly manifested in the parietotemporal cortex
(19,23,24). Some investigators have also reported reduced
functional activity in the frontal cortex, although typically
to a lesser extent than in parietotemporal regions
(22,25,26). In addition, disturbed patterns of lateralized
metabolic activity characterize a subgroupof AD patients,
with the direction of lateralized abnormalities correlating
with patterns of neuropsychological deficit (27â€”29).
Imaging studies in depressed patients have observed a
variety of abnormalities including reductions in blood flow
or metabolism globally and in selective frontal, temporal,
parietal and subcortical regions (30â€”39).Some investiga
tors have emphasized frontal cortex abnormalities in MD
and have suggested that findingsof a pronounced parieto
temporal deficit should favor an AD diagnosis, whereas a
pattern of parietotemporal preservation with frontal cortex
deficit may indicate MD (9,10). However, this inference is
questionable. First, in the bulkofprevious imagingstudies,
MD samples have been relatively young patients with only
mild to moderate symptomatology. For comparison with
AD, samples ofelderly and severely depressed patients are
of greater relevance. Second, a focus on frontal cortex
abnormalities would likely provide an incomplete view of
the topographic deficits in MD.
It has been increasingly recognized that complex psy
chological phenomena are subserved by networks of spa
tially distributed brain regions (40â€”42).These intrinsic net
works, defined as patterns of covariance among brain
regions, may not correspond to the spatial organization
frequently imposed on brain imagingdata. A common ap
proach to identifying topographic abnormalities has been
to average values in anatomically adjacent regions into
groupings by lobe (33,43,44) or brain quadrant (e.g., left
and rightanteriorand posterior) (45,46). Besides reducing
spatialresolution, such transformationspresume that there
are greater functional interrelations or covariance among
the regions within a groupingthan between regions repre
sented in differentgroupings and contradict the view that
functional networks may have wide spatial distribution.
Wecontrastedregionalcerebralbloodflowinmatchedgroupsof
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ifferentiating Alzheimer's disease (AD) from major
depression (MD), while crucial for treatmentplanning,is at
times difficult (1,2). Only 80% of antemortem AD diag
noses may be validated by neuropathological findings (3-5)
and some elderly depressed patients have marked cogni
tive impairment(6,7). It has been suggested that AD and
MD may each be associated with distinct topographic ab
normalities of cerebral blood flow (CBF) and metabolism
(8,9). However, there has yet to be extensive, direct com
parison of these conditions using functional imaging tech
niques (10).
A largenumberof studies have demonstratedthatAD is
associated with a global cortical reduction in blood flow
andmetabolism(11â€”14),as well as a characteristicdeficit in
panetotemporal cortex, with relative preservation in cal
carine and sensorimotor regions (15â€”19).There is evidence
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and (3)whether the previously determinednetwork abnor
mality in major depression was stable or altered by the
inclusion in the blindSSM analysis of a patientsamplewith
known and possibly distinct topographic disturbance.
MATERIALS AND METhODS
Patient Population
The study cohort comprised 30 AD, 30 MD and 30 normal
controls. The MD and normal subjects were selected blind to
rCBF results from the larger, previously reported samples of 41
MDand40controlsto createequally-sizedgroupsmatchedon the
mean, variance and shape of distributionsof age, end-tidalPCO2
and systolic and diastolic blood pressure and the distributionof
gender (Table 1). The MD patients met the Research Diagnostic
Criteria(52)formajordepressivedisorderandendogenoussub
type usingthe Schedulefor AffectiveDisordersand Schizophre
ma (53). Participationrequired a score of 18 or greater on the
Hamilton Rating Scale for Depression (HRSD) (54). Exclusion
criteriahave been previously reported(47). Laboratorytests (un
nalysis, SMA2O,CBC, thyroid function) and chest roentgenogram
were within normal limits. With the exception of low doses of
lorazepam, the MD sample was withdrawn from psychotropic
medicationat least 5 days before rCBF measurement. The mean
(Â±s.d.)psychotropicwashout was 12.73 Â±6.11 days (median, 10
days), with an upper limit of 28 days taken for longer drug-free
periods. No lorazepamwas administeredwithin 10 hrof the mea
surement.The averagelorazepamdose 24 hrbefore rCBF assess
mentwas 0.99 Â±0.79 mg (range0â€”3.0mg). Length of medication
washout and the presence, absence or dosage of lorazepamwere
not associatedwithCBFparameters.Thenormalcontrolswere
paidvolunteers who were negative for psychiatricand neurologic
history. None had taken prescriptionor nonprescriptionmedica
tion for at least 2 wk before rCBF measurement.
TheAD samplemetDSM-IIIcriteriaforprimarydegenerative
dementia at durationsof illness for less than 1 yr and NINCDS
ADRDA criteria (3) for probable Alzheimer's disease at durations
of 1 yr or (onger. These outpatients underwent comprehensive
neurological,CT, EEG, neuropsychologicalexaminations and
MRIandcerebrospinalfluidstudies,if indicated.Laboratorytests
werewithinnormalimits.AllAD patientswerenegativeforthe
presence of major depression, delusions or hallucinations and had
negative psychiatric histories. They were free of psychotropic
medicationfor atleast 1mo priorto rCBFmeasurement.Ofthe 30
ADpatients,27hadbeenincludedina previouslyreportedsample
of 36 patients (55). Patientswere excluded from this study due to
incomplete rCBF data (n = 2), concurrent medication, psychiatric
history (n = 5) or to produce adequate matching of the groups
(n = 2). Three newly studied AD patientswere added to achieve
comparablesample sizes.
The modified Mini-State examination (mMMS, total possible
score of 57)was used to quantifythe severityof globalcognitive
impairment(56,57).Capacitytoconductactivitiesofdailylifewas
assessed with the firstpartof the Blessed Dementia RatingScale
(BDRS)(58).TheAD samplewas weightedwithcases of short
illnessduration(mean= 3.06yr. s.d. = 1.77,range = 035â€”6yr)
and relatively mild to moderate cognitive impairment (mean
mMMS = 30.80, s.d. = 14.61, range, 0â€”53)and functional inca
pacity (mean BDRS = 7.12. s.d. = 3.04, range, 3â€”14).All 90
subjects were right handed.
Consequently, the identification that a clinical sample has a
deficit in an a priori grouping of brain regions neither en
sures that the topographic deficit provides an exhaustive
description of the abnormal network nor does it guarantee
that the deficit is consistent within the grouping.
These and related problems were illustrated in a previ
ous paper in this series (47). By using the â€˜33Xetechnique
to measure regional cerebral blood flow (rCBF), we con
trasted matched groups of relatively elderly MD patients
and normal controls, applying both conventional multivari
ate statistical techniques and the Scaled SubprofileModel
(SSM) that was developed to identify abnormalfunctional
networks in clinical samples (48). The depressed grouphad
a marked global reduction in CBF, as well as a specific
topographic deficit. By SSM, the topographic deficit in the
MD group was due to CBF reductions in selective frontal,
central, superior temporal and anterior parietal regions.
This pattern appeared to correspond to the parallel distrib
uted network of prefrontal and parietotemporal polymodal
association areas that had been implicated in arousal, at
tentional and motivational functions, as well as represen
tational cognitive processes (42,49â€”51).Within the MD
group, abnormality in this network increased both as a
function of patient age and severity of depressive symp
toms.
Our previous findings that MD was associated with a
global reduction in cortical CBF and with a topographic
deficit involving selective frontal, temporal and parietal
regions raised concern about the specificity of the deficits
in MD as compared to AD. Here, we examine whether
these conditions are associated with distinct topographic
abnormalities. A second aim was to investigate the reliabil
ity andvalidity of SSM. Since it is alreadyestablished that
AD is associated with a characteristic parietotemporal def
icit, we sought to determine: (1) whether an abnormal
network corresponding to a parietotemporaldeficit would
emerge when adding a sample of AD patients to the previ
ously studied MD and normalcontrol samples, (2)whether
the severity of cognitive impairmentwithin the AD patients
covaried with manifestation of such a network abnormality
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TABLE 2
DescriptiveStatisticsand ANCOVA Resultsfor Global CBF Values
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M2= sb-unknownmodelusedtodetermineflowparameters;Ml = thefour-unknownmodel;ISI= inftialslopeindex;f@= fastcompartment,
gray-matterflowrate(inmlper1009 permm);CBF15= flowrateInall perfusedtissue;k@= siowcompartment,whftematterdearance;andw9
= relatWe weight of gray matter to total perfused tissue.
rCBF Measurement
Procedures for rCBF measurement have been previously de
tailed (47).Assessmentswere made under resting, supinecondi
tions in a quiet, darkened room with weighted blinders placed
over the eyes. A commercial device (Novo Cerebrograph 32c,
Copenhagen,Denmark)was used with head positioningestab
lished by determining the orientation of a helmet housing 32 scm
tillation detectors (16 per hemisphere) in relation to light markers
alignedto the canthomeatalline. Extensive qualitycontrol proce
dures were used as detailed elsewhere (59). End-tidalPCO2was
monitored during the 11-mmmeasurement period and blood pres
sure was determined following the measurement. aearance
curves were analyzed both with a six-unknown model (M2),
whichprovidesgreatersensitivityunderlow flowconditionsand
more accurate artifactremoval, and the traditionalfour-unknown
model (Ml) (60,61). The major dependent variable was the M2
initial slope index (M2 IS!) (62). The statistical analysis proce
dures are described in the Appendix.
RESULTS
The three groups were equivalent in the distributionof
gender (Table 1). ANOVAS (groupedby sex) indicatedthat
the groupswere also equivalent in age, end-tidalPCO2and
blood pressure values. There was a main effect of sex on
age (p = 0.01), with females (mean Â±s.d., 67.38 Â±7.71)
being older thanmales (63.09 Â±8.57), a patternmanifested
in all three groups. No other main effect or interaction was
significant. Across the groups, global flow was higher in
females thanin males (p < 0.02), despite the age difference.
Global flow positively correlatedwith PCO2(r = 0.33, p <
0.002).
Global Flow Effects
As seen in Table 2, the ANCOVAS on global values
yielded a main effect of group for every CBF parameter.
With the exception of M2 wg, both the MD and AD groups
for each parameterhad significantlylower values thannor
mal controls but did not differ from each other. The MD
and AD groups had marked and equivalent global reduc
tions in both gray matter flow (Lb)and white-matter clear
ance (k2).M2 wg is an anatomic index, assessing the rela
tive amount of fast-clearingtissue (graymatter)relative to
total perfused tissue. The groups also differedsignificantly
in wg, with post hoc comparisons indicating that the AD
group had reduced wg relative to both the MD group (p <
0.05) and normal controls (p < 0.01), with no difference
between the latter two groups. This suggested a loss of
cortical gray matter in the AD group (63). The group dif
ferences in cell loss did not influence the global or regional
CBF measures. Unlike most applications of PET or
SPECT (64) with agents that remain fixed intracellularly,
the â€˜33Xetechnique quantifiesCBF only in perfused tissue.
GlObalandTopographicAbnormalities:SSM
The terms and procedures involved in the SSM analysis
aredefinedin the Appendix. In applyingSSM to the M2 ISI
values, four topographic structures (GISs) were identified
that accounted for 49% of the subject by region variance
(SRPs). Individual differences in manifesting these topo
graphic patterns (SSFs) accounted for 23% of the variance
in raw global CBF. Therefore, a substantialportion of the
variability in global CBF was due to topographic effects.
To determine SSM's parameter of a region-independent
global value (GSF), the contributions of these four topo
graphic patterns to raw global values was removed.
The mean GSF (in 151units)was 46.42 Â±6.74 for normal
controls, 42.97 Â±7.06 for the MD group and 43.48 Â±5.72
for the AD group. An ANCOVA on GSF values yielded a
significant effect of the PCO2 covariate (p = 0.002) and a
trend for a main effect of group (p = 0M9). The MD pa
tients had significantly lower GSF values than controls
(p = 0.03), while AD patients tended to have lower values
thancontrols (p = 0.08). The differences among the groups
in SSM's estimate of global flow were smaller than the
differences observed in raw global flow. This was because
in both patient groups the deficits in raw global flow were
due to a combination of diffuse and focal abnormalities.
SSM removes focal effects in estimating the GSF.
1092 TheJournalofNuclearMedicineâ€¢Vol.34â€¢No.7â€¢July1993






GIS1 GIS2 GIS3 GIS4 GIS1 GIS2 GIS3




Table 3 presents the regional covariance patterns de
scribedby each GIS. For this study, the signs of the region
weights in Table 3 were oriented so that negative values
reflect regions of relative flow deficit in the clinical groups.
The first topographic structure defined a clear anterior
posteriordimension, characterizedby relatively higheran
terior than posterior CBF. The MD and normal controls
were equivalent in this pattern of â€˜hyperfrontality.'Corn
pared to both these groups, the AD sample had exagger
ated â€˜hyperfrontality,'due to posterior flow deficits. The
second structuredescribed the only abnormaltopography
in the MD group. As shown in Figure 2, this deficit cone
sponded to reductionsin selective frontal, central, superior
temporaland anteriorparietalregions. Only the AD group
had abnormalmanifestationof the thirdtopographicstruc
ture, which is also illustratedin Figure 2. This covariance
pattern closely conformed to the classic parietotemporal
deficit previously reported in AD. It involved flow deficits
in bilateraltemporal and parietalregions with a somewhat
greater involvement of the left than right temporal areas.
The last structurereflectedpatternsof asymmetry. The AD
group was also abnormalin displaying this pattern which
was characterizedby relatively higher right than left CBF
in selective frontal and parietalregions in the normal con
trols and MD patients.
Stabllfty of SSM Parameters
Compared to our previous report (47), the findings ob
tamed here involved blindly excluding 11 MD and 10 con
trol subjects and introducing30 AD patients. We examined
the stability of the identification of regional networks
across the two studies and determinedwhich topographic
pattern newly emerged with the introduction of AD pa




Figure 1 presents the mean scores of the three groupson
the four topographic structures. A repeated measures
MANCOVA was conducted on these scores (SSFs). There
was a main effect of the group (p = 0.01) and an interaction
between the group and topographicstructure(p < 0.0001).
Therewas also an interactionbetween sex andtopographic
structure (p = 0.02) indicating gender differences in topog
raphy. To determinethe source of the significantmultivari
ate effects of the diagnostic group, follow-up ANCOVAs
were conducted on each 5SF. In all analyses, the main
effect of the groupwas significant(SSF1: p < 0.05; SSF2:
p < 0.0001; SSF3: p < 0.005; SSF4: p < 0.05). The AD
group differed from normal controls in manifesting each of
the four topographic structures (0.05 > p > 0.0005). The
MD groupdifferedfrom normalcontrols only in SSF2 (p <
0.0001). The MD and AD groups differed in manifesting
three of the four topographic patterns (SSF1: p < 0.02;
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(two group analysis followed by three group analysis) rep
resents the first attempt to distinguish when an illness pro
duces abnormalitiesin normal patterns of brain region in
teraction and where an illness imposes new patterning.
ClinicalCorrelatesofGlobalandTopographIcDefIcits
The relationships within the AD group between illness
severity and CBF parameterswere determined. The clini
cal indices were mMMS and BDRS scores, duration of
illness and age at AD onset. The CBF parameters were raw
global CBF, the GSF and scores on the four topographic
structures (SSFs). The clinical measures were used as pre
dictors, together with PCO2values, in multiple regression
analyses on each CBF parameter (Table 4). Separate anal
yses were conducted for the mMMS and BDRS. Patients
with greater cognitive impairment (lower mMMS scores)
had lower global flow. There were particularlystrong rela
tions between mMMS scores and scores on the thirdtopo
graphicstructure, the network introducedby the AD sam
pie. Patientswith greatercognitive impairmenthad a more
severe parietotemporaldeficit. Patients with longer dura
tion of AD had more abnormal scores on the first topo
graphicstructure, suggesting that at longer illness duration
the degree of posterior flow deficit and relative â€˜hyperfron
tality' increased. As with the mMMS, higher BDRS scores
(indicating greater impairment in activities of daily life)
were associated with lower raw global CBF and lower
GSF. However, unlike the mMMS, the BDRS had weak
relations with topographicdeficits.
In our previous report (47), we found that older MD
patients and those with greater symptomatic severity, as
assessed by the HRSD, were more abnormalon the second
topographic structure (the regional pattern associated with
depressive illness). In the subsample of MD patients in
cluded here, the relationshipbetween HRSD (mean Â±s.d.,
32.53 Â±7.63) and SSF2 scores was maintained (r = 0.37, p
< 0.05). However, possibly due to the restricted age range
needed for groupmatching, there was no longer a relation
ship between MD patient age and SSF2 scores (r = â€”0.06,
ns). The mMMS was administered to 16 of the 30 MD
patients. As expected, MD patients, althoughscoring in an
impaired range, had considerably higher mMMS scores
(46.31 Â±6.46, range 33â€”53)than the AD group (p =
0.0002). Within the MD group, there were no relationships
between mMMS scores and any of the four topographic
profiles. Compared to the AD group, the range and van
ability in mMMS scores was reduced in the MD group.
Nonetheless, the association between cognitive impair
ment and scores on the thirdtopographicstructure(SSF3)
appearedto be specific to the AD group.
Comparison of SSMto a Conventional Statistical
Approach
To contrast the findingswith SSM, a conventional mul
tivaniate analysis was conducted as described in the Ap
pendix. The MANCOVA on the 32 ratio scores yielded a
significant group by region interaction (p < 0.01). Two
linear discniminantfunctions that maximized group sepa
FiGURE2. (Fop)Thesecondtopographicstructureidentifiedby
the SSM. The only topographic abnOrmality in patients wfth major
depressionwasin thisprofile.Darkenedregionswereareasthat
significantly partidpated in this network and defined the topographic
bloodflowdeflcftsin majordepression.(Bottom)Thethirdtopo
grapt@icstructureidentifiedbytheSSM.Thispatietotemporalpattern
was introducedby patientsw@ AD and the extentto wh@hthese
patientsmanifesteddeflcftsin this patterncorralatedstronglywffli
theirdegreeofcognitiveimpairment.Relativeorientationofthede
tectors in the helmet is denoted by shape. F = frontal; C = central;
T = temporal,P = patietal;0 = occipital.
identified in contrast to the four patterns obtained here. In
both studies, the first structure (GIS1) described an ante
rior-posteriordimension. The correlation was nearly per
fect between the weights of the 32 regions in the structure
identified here and in our previous report (r = 0.94, p <
0.0001). The correlation in scores for manifesting this to
pography (SSF1) for the 60 subjects (30 MD and 30 con
trols) common to both studies was also robust (r = 0.94, p
< 0.0001). Similarly, the correlation was 0.96 (p < 0.0001)
for both the region weights and the subject scores for the
second structurewhich was markedly abnormalin MD in
both studies. The fourth structure obtained here mainly
involved patterns of asymmetry in selective frontal and
parietal regions. This corresponded to the third structure in
our priorstudy with correlationsof0.74 and0.81 for region
weights and subject scores, respectively (p < 0.0001).
These findings demonstrated strong stability for SSM's
blind determinationof topographic effects, despite reduc
ing the numberof MD andnormalsubjects and introducing
AD patients. Most critically, these findings indicate that
the third topographic structure (GIS3) identified here is a
new regional pattern that emerged due to the inclusion of
AD patients. This pattern is not characteristic of normal
controls or MD. Since this parietotemporalnetwork is only
manifestedwith the inclusion of AD patients, it is the most
likely to reflect the primary pathophysiology of this condi
tion. Nonetheless, the AD group was also abnormal in
manifesting the remaining three patterns. This indicated
that, in additionto being characterizedby a parietotempo
ral deficit, AD alters the expression of regional patterns
that are characteristic of normal functioning. To our
knowledge, the serial analytic approach exemplified here
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mMMS, BDRS, duration of illness and age at onset values
within the AD group. No significanteffects emerged. The
first discniminant pattern, detailed by the conventional
multivaniate approach as sensitive to AD, departed from
classic descriptions of the parietotemporal deficit. In line
with these descriptions, this pattern reflected bilateral pa
nietal CBF reductions with preservation in primary sensory
andmotor areas. However, it also included a flow deficit in
a right-sidedprefrontalregionwith relative flow elevations
in a bilateral anterior temporal region and a right-sided
posterior parietal region. Part of the difficulty encountered
by the conventional approachwas due to poor separation
of global and topographic effects. Despite being derived
from analysis of ratio scores (normalizationby the global
mean), there was still a substantial correlation between
scores on the first function and global CBF (r = 0.49, p <
0.0001).
As another comparative test of both approaches within
the AD group, correlations were examined for each brain
regionbetween CBF values and rnMMSscores. In one set
of analyses, the regional values were normalized by the
GSF with SSM's measure of global flow stripped of the
influence of topographic effects. In a second set of analy
ses, the regionalvalues were normalizedby the raw global
mean. In both analyses, bilaterally averaged CBF values
were used to reduce the numberof correlationsperformed.
Figure 3 presents the findings. With GSF normalization,
trends or statistical significance (p < 0. 1)was obtained for
six correlations (1.6 expected by chance, assuming
independence). These effects unifonnly indicated that
greatercognitive impairmentwas associated with reduced
regional CBF in parietotemporal cortex. With normaliza
tion by the raw global mean, five effects were obtained.
Contrary to intuition, three of these correlations reflected
inverse relations between mMMS scores and regional CBF
values. The involved regions corresponded to areas
thought to be least compromised by AD (15â€”19).In this
light, the elevated ratio values at these regions were due to
reductions of global CBF in AD patients who had marked
topographic deficits in other brain areas. Further, with









rationin regionalpatternswere obtainedand subjects were
scored for their manifestation of these regional proffles.
The groups differedin manifestingeach of the proffles(p <
0.0001). For the first structure, normals scored significantly
higherthanthe MD group(p < 0.0001), who in turnscored
higherthanthe AD group(p < 0.0002). Only the MD group
was abnormal in the second pattern, differingfrom both
controls and AD patients (p < 0.0001).
Table 5.presents the results of regression analyses cx
amining the relationship between subjects' scores on the
four SSM topographic structures (SSF5) and their scores
on the two discriminantfunctions. Scores on each of the
four SSM patterns were significantly associated with
scores on the two discriminant patterns. To maximize
group separation, the conventional approach had corn
bined elements of the more discrete SSM patterns. This
was supported by examination of the regional weights in
the discriminantfunctions. For the first function, the cor
relations between these structure coefficients (z-trans
formed)andthe regionweights for the fourGISs were 0.54,
0.43,0.53and0.33,respectively(0.06p< 0.002).Forthe
second function, the correlations were 0.54 (p = 0.001),
â€”0.63(p = 0.0001), 0.18 (ns) and 0.33 (p = 0.06), respec
tively. These analysis indicated that the topographic pat
terns detailed by the discriminantfunction were an amal
gam of the more discrete networks revealed by SSM.
The discniminant function patterns showed relatively
poor stability. In the previous study restricted to MD and
normal controls, a single discriminant function was ob
tamed. The region weights for this earlier pattern cone
lated 0.53 and â€”0.53(p = 0.002) with the weights on the
two functions obtained here. For subject scores on these
patterns, the correlations were 0.74 and â€”0.53(p <
0.0001). Validity was tested by examining the relationship













Reiationsbetween Scores on Four SSM Topographic
Structuresand Scores on the Two DesctiptiveDiscriminant
Functions
SSF10.330.00010.280.001SSF20.440.0001â€”0.470.0001SSF30.400.00010.150.08SSF40.310.00010.310.0004
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Twopred@vedisaiminantanalyseswerecOndUCtedclassifyingsubjectsasnormalcontrois,depressedpatientsorasADpatients.Oneanalysis
usedthefourSSFscoresandtheGSFforclassffication.Theothermodelusedsubjectscoresonthetwodescdptivediscnin*iantfunctionsandglobal
mean CBF The values indicatethe numberof subjectsassignedto a particulargroup in each analysisas a functionof their clinicaldiagnosis.
FiGURE3. (Left)Correlationsin Alzheimer'spatientsbetween
bilaterallyaveragedregionalCBF values nOrmalIZedby the GSF
and scoreson the modffiedMiniMentalStateexamination.Signifi
cal-itcorrelationSindicatethat greatercognitiveimpairmentwas as
sociatedwith lowerbloodflow. TheseeffectsoccurredIn the pan
etotemporalcortex@(Right)Correlationsusingthe rawglobalmean
for normal@abon.This normaI@ationresultedin a scatteredpattern,
withgreatercognitiveimpairmentbeingassociatedwithhigherblood
flow in three regions.Theseregionsare traditiOnallythoughtto be
leastaffectedbyAD.*p < 0.10;â€œp< 0.05;***p< 0.01.
regions had positive associations between mMMS scores
and CBF values, and these effects were marginal(p < 0.1).
The contribution of the parietotemporal deficit to global
mean values reduced the magnitude of positive associa
tions within the topographicdistributionof this deficit and
artificially created negative associations in areas minimally
compromised by AD.
The utility of each method for diagnostic classffication
was also examined. For SSM, scores on the four SSFs and
the GSF were submitted to a discriminant classification
analysis, predicting membership in the three groups. In a
similar classification analysis, subject scores on the two
descriptive discniminant functions and the global mean
CBF served as predictors. As seen in Table 6, classification
accuracy clearly exceeded chance (33%) with both sets of
predictors (p < 0.0001), but classification accuracy was far
fromperfect. Overall, 66.7%of the subjects were correctly
classified using the SSM indices and 75.6%were correctly
classified using the measures derived with the conventional
multivaniate approach. Despite the fact that the conven
tional approach was not blind to group membership and
had optimized group separation when deriving the topo
graphic measures, the two methods were relatively corn
parablewhen used for classification purposes.
TABLE 6
















1096 The Journal of Nudear Medicineâ€¢Vol. 34 â€¢No. 7 â€¢July 1993
DISCUSSION
The MD and AD groups had marked and equivalent
global CBF reductions. Global deficits in CBF and metab
olism frequently have been noted in AD (11â€”14)but less
consistently in MD (30â€”39,46).The equivalence of the
clinical groups in global deficits may have been related to our
concentration on elderly MD patients with severe depressive
symptoms and AD patients with relatively short disease du
rationand mild to moderatecognitive impairment.
In both the MD and AD groups, the reductions in raw
global CBF were partly due to topographic deficits. Con
sequently, the abnormalities in GSF, SSM's measure of
region-independent global CBF, were smaller in magni
tude. Nonetheless, both clinical samples hadreduced GSF.
This suggests that in additionto the processes that disrupt
regional patterns, both conditions are characterized by a
disturbancethat reduces CBF across the cortex. The latter
may involve dysfunction in subcortical nuclei with wide
spreadcorticalprojection(65,66). In the AD group, the def
icits in rawglobalCBF andin GSF covaniedwith the degree
of cognitive impairmentand of functionalincapacity.
The primaryaim of this study was to determinewhether
MD andAD could be distinguishedin topographicdeficits.
Using either SSM or conventional statistical techniques,
such specificity was established. We had previously iden
tilled an abnormal regional network in MD and showed
that the extent of its abnormalitycorrelated with the Se
verity of depressive symptoms (47). These earlier findings
were unalteredin this study and SSM parameters, derived
blind to group membership, showed strong stability despite
including a large AD group. By SSM, the regional abnor
malities in MD are due to CBF reductions in a network
comprising selective frontal, central, superior temporal and
anteriorparietalregions. This may correspond to the par
allel distributed network involving strong reciprocal con
nectivity between polymodal association areas in prefron
tal cortex and the inferiorpanietallobule and the superior
temporal sulcus (41,42,67).
A new topographicstructureemergedwith the inclusion
of the AD group. Only the AD group was abnormal in
manifesting this pattern, which corresponded closely to
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classic descriptions of the panietotemporalAD deficit (15â€”
19). In support of this was the extent of cognitive impair
ment in AD that correlated strongly with the degree of
abnormalityin this network. These findings indicated that
the abnormalparietotemporaltopography in AD does not
reflect disruption of a regional pattern intrinsic to normal
functioning. Rather, it is due to AD imposinga new pattern
of covariance on parietotemporalbrain regions.
The AD group was also abnormal in manifesting the
other three regional patterns previously identified in the
study restricted to normal controls and MD patients. The
panietotemporaldeficit in AD would be expected to disrupt
normal patterns of regional interaction in networks that
include the parietotemporal cortex. Specifically, due to
reduced CBF in these posterior regions, the AD group had
exaggerated â€˜hyperfrontality,'thereby showing enhanced
manifestation of the first SSM network that described an
anterior-posteriordimension. The parietotemporaldeficit
partially overlapped with the regional abnormalitiesasso
ciated with MD. Both clinical conditions were associated
with superior temporal and anterior parietal CBF reduc
tions. This, and the fact that some AD patients may also
have had compromised frontal regions, resulted in abnor
mal manifestation in the AD group of the second regional
profile. Finally, others have shown that the panietotempo
ral deficit is variably expressed to a greater extent in the
left or right hemisphere in a substantial number of AD
patients (27â€”29).This likely accounted for why the AD
group was disturbed in the fourth topographic profile which
described normal patterns of asymmetry in frontal and
panietal regions.
In future work, it may prove helpful to make this dis
tinction between a disease introducinga new organization
of interactions among brain regions and a disease second
ally disruptingnormalpatterns. The identificationof new
regional patterningshould be of greater relevance for de
termining pathophysiology and, perhaps, etiology. For cx
ample, although the cause of the AD parietotemporaldef
icit in CBF and metabolism is still unknown, it is
noteworthy that its regional distributionhas considerable
overlap with the cortical areas with the greatest density of
histopathological abnormalities, including large neuron
loss, neuriticplaques andneurofibrillarytangles (68â€”70).In
contrast, secondary disruptions of regional networks
present in normal functioning may be of importance in
accounting for associated symptoms including patterns of
behavioral disturbance. The findings also demonstrate that
diseases may be multidimensional in altering patterns of
regional interaction. This multidimensionality suggests
that, for purposes of differentialdiagnosis, simple visual
inspection of brainimages may have critical limitations. In
addition, the widely distributed nature of the abnormal
network in MD makes its visual identificationdifficult.
In this study, the use of conventional multivariatesta
tistical techniques also indicated that the MD and AD
groups had distinct topographic abnormalities. However,
limitations were identified in the application of these tech
niques to complex imagingdata. In our previous report,we
concentrated on the problem such techniques have in sep
aratingtopographic from global effects (47,48). This con
foundingof global and topographiceffects occurred when
using both raw or normalized values as dependent mea
sures (47). Likewise in this study, despite use of the raw
global mean to normalize regionalvalues, there was con
siderablecontaminationof regionalandglobal effects. Spe
cifically, this contamination distorted the topographic pro
ifies yielded by the descriptive discriminant analysis. It
also obscured the relationships in the AD group between
regional CBF values and the degree of cognitive impair
ment, thus producing some statistically significant, but
clearly artifactual,effects. The findingsof this three-group
study also illustrate additional limitations. Discniminant
analysis, as used here, is designed to yield the smallest
number of topographic profiles that simultaneously maxi
mize group separation (71, 72). Consequently, intrinsic to
pographic dimensions on which groups do not differ cannot
be identified. Group differences on independent topo
graphicdimensions may be combined into a single regional
proffleor, conversely, an intrinsicregionalpatternmay be
disjointedly represented as separate topographic dimen
sions to achieve better group separation. These method
ological concerns were underscored by the findings regard
ing the stability and the validity of the topographicprofiles
derived with the conventional multivariate approach. In
contrast to SSM, the discniminantprofile we had previ
ously identified as distinguishing MD patients and normal
controls showed poor stability with the introduction of a
new clinical group. Also in contrast to SSM, neitherof the
discniminant profiles obtained in this study were associated
with clinical indices in the AD group.
Although both SSM and the conventional approach in
dicated that on average there were marked global and
topographic differences among the groups, there was still
considerable overlap among the groups in the derived in
dices. Consequently, in the classification analyses, neither
approach demonstrated strong utility for purposes of dif
ferentialdiagnosis. Partof the problemhere may be related
to the poor spatialresolutionof the lateralprobe technique.
Since SPEC!' and PET offer superior spatial resolution as
well as the capacity to image subcortical structures, the
power of SSM to identify stable sets of complex regional
networks and to score patients in manifesting these pat
terns should prove critical in future applications of these
imaging modalities.
CONCLUSION
We found that patient groups with MD and AD had
equivalent reductions in global cortical CBF, but distinct
topographic abnormalities. A single regional pattern was
abnormal in major depression and manifestation of this
abnormalitycovaniedwith the severity of depressive symp
toms. We provided evidence that AD imposes a new re
gional organization and that the severity of cognitive im
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pairment in AD correlates strongly with manifestation of
this parietotemporal deficit. In addition, AD modulates the
expression of the regionalpatternscharacteristicof normal
function, resulting in widespread patterns of abnormality.
The capacity to identify distinct topographic proffles as
being characteristicof MD and AD supports the possibility
that with further development functional neunoimaging
techniques may contributeto differentialdiagnosis in these
conditions.
APPENDIX@STAI1S11CALPROCEDURES
Evaluation of Group Matching and Global CBF Effects
The adequacyof matchingacross the threegroupswas as
sessed by conducting ANOVAS on the continuous matching van
ables with group and sex as between-subject factors and by a
chi-squareanalysison the distributionof gender.GlobalCBF
parameterswerecomputedas themeanof rawvaluesacrossthe
32 detectors. ANCOVAs were used to examine group differences
in global cortical CBF with group and sex as between-subject
factors and age and PCO2as covaniates.To identifythe natureof
differencesamongthe groups, protected t-tests on covaniate-ad
justed means were used for post hoc comparisons.
Scaled Subprofile Model
Themathematicalpropertiesof SSManditsstatisticalassump
tions have been descnl,ed elsewhere (48,73). Conceptually, SSM
posits that for each individual each regional CBF or metabolic
value comprises three components. The first component is a dif
fuse or region-independent GSF that modulates or scales all re
gionalvaluesfor a givenindividual.TheGSFis similarto the
meanCBForCMRacrossbrainregions,butthecontributionsof
topographicpatternsare removed in the calculationof GSF. The
secondcomponentis theGroupMeanProfile(GMP),whichcor
responds to the average topographic distribution manifested
across a total sample. Ignoring differences that may pertain to
subject groupings, this mean component is the best descriptor of
the similarityacross subjects in topography.The thirdcomponent
is the SRP and corresponds to the variability that is both subject
andbrainregiondependent,thatis, theregionalpatternuniqueto
each subject. Therefore, for each subject, j, and for each brain
region,i, rCBF1@maybe expressedas:
rCBF@= GSFJ X GMP@x (1 + SRP@).
SSMconceivesof theSRPsasbeingcomposedof independent
sets of topographic networks. These networks correspond to dif
ferentpatternsof covarianceamongbrainregions.Thecontribu
tionof a particularbrainregionto a network,thatis, its impor
tance in the covaniancerelationships within the pattern, is
quantifiedby its weight on the corresponding015. Therefore, the
GIS is a vector of regionalvalues, representingthe covaniance
relationshipsamongbrain regions. Furthermore, since different
individuals manifest these relationships to greater or lesser cx
tents,a5SFcanbederivedtocapturetheindividualdifferencesin
manifestingeachnetwork.Foreachsubject,j, brainregion,i, and







are due to individual differences in both the region-independent
GSF andin manifestationof topographicprofiles(SSF3s).Once
theSSFsarederived,thecontributionsof theseindividualdiffer
ences in topographycanbe removedfromtherawglobalmeans,
resultingin computationof the GSF. In simplifiedform, this may
be expressedas:
ln(GSF@)= in(CBF@)â€”@ B@x SSF1@@+ B@. Eq. 3
k= 1
Foreachnetwork,k, B@is a constantcorrespondingto the beta




data from the total sample, blind to group membership. In this
study, the rCBF values of 90 subjects were submitted to the
model.Naturallogarithmictransformationis appliedto the raw
rCBF values at each brain region, allowing the multiplicative
relations between GSFJ, GMP1and SRP@,(Equation 1) to be cx
pressedadditively.To producethe approximationof the SRPs
(Equation1), the meanvalueat eachregion,determinedacross
the totalsample(rCBF@)and each subject'sglObalmeanvalue
(CBF@),weresubtractedfromeachsubject's regionalvalues(rCB
F.). SinceGSF is unknownat thispoint,the globalmeanvalue
(CBF@)is usedas an approximation.Thissubtractionprocedure
correspondsto removingthe GMP and an approximationof the
GSFfromthe regionalvaluesof each subject.Since these sub
tractions were performed after logarithmic transformation, the
Sm' valuesaresimilarto the ratioscoresoftenusedin conven
tional analyses where raw regional values are normalized by the
subject'sglObalmean.
After isolating the SRPs, the values are arrangedso that cot
umnscorrespondto subjectsandrows correspondto brainre
gionsandthebetween-subjectprofilecovariancematrixis com
puted. A principal-componentsfactor analysis (PCA) is
performedon thisSRPcovaniancematrixanda set of unrotated
factors(eigenvectors)is extracted.The PCAiterativelyextracts
independentlinearfactorsthatmaximallyaccountforSRPvan
ance. The weights on each factor quantify the extent to which
each topographicpatternis manifested by each subject and cor
respondto the SSFs. By definition,the meanscoreof the total
sampleforeach5SF is zero,indicatingthat5SFscorescapturethe
relative and not absolute extent to which a topographic structure is
Eq.1
In clinicalresearchapplicationsof brainimaging,the topo
graphicalterationsproducedby disease entitieswill be reflectedin
the SRP, the variabilitythatis both subject(e.g., disease)and
brainregion specific. However, this source of variabilityis likely
to be small when compared to the large individualdifferences in
global values and the between-region variability associated with
the average profile across individuals (47). For example, in the
currentstudy, a repeatedmeasures ANOVA (diagnosticgroup [3
levels)by brainregion[32levelsl)was conductedon therawISI
values.Thevariabilitythatwas bothsubject-andregion-depen
dent comprised only 12.5%of the total variability. A significant
groupby regioninteractionwas obtained(p < 0.0001)indicating
thatthegroupsdifferedintopographiceffects.However,thesum
of squaresassociatedwith this interactioncomprisedonly 5.6%of
the subject by region variability and thus, only 07% of the total
sum of squares. As a method of signal amplification, an SSM
analysis begins by isolating the SRPs, thereby removing consid
erable extraneous variance.
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manifested. Using standard regression techniques, the loading of
each brainregionon each factoris also determined,providinga first
approximationto the spatialrepresentationof the networkor GIS.
The number offactors to retain is determined by applying the Scree
test (73) to the set offactor eigenvalues and by examining the extent
towhichtheSSFsaccountforthevarianceinglObalCBFvalues.
Following Equation 3, the SSFs are submitted to a simulta
neous multiple regression analysis, predicting the global mean
CBF values (ln[CBF@]).The GSF corresponds to the residual
between predicted and obtained values. Adding the intercept term
to the residualsandtakingtheantilogof thisvalueproducesthe
final form of the GSF in the original CBF units. The beta coeffi
cient for each SSFk from this regression characterizesthe extent
to which the particulartopographicstructurecontributedto global
meanvalues. These regressioncoefficientsare addedas a con
stant (or offset) to the region loadings of the respective 015. This
correctsfor the distortionin regionweightsintroducedby nor
malizingby the subjects'globalmeanvalues in the computationof
SRPs. The standard error associated with each beta coefficient is
used to establish confidence boundariesfor each GIS in identify
ing the set of regions most critical in definingthe topographic
pattern. Thus, the variability in rCBF is partitioned so that each
subjectis scoredin theirmanifestationof each one of a set of
topographical profiles, as well as in their region-independent
global CBF. In this study, to determine whether the groups dif
fered in glObalflow (GSF) or topographic organization (SSFs),
standard ANCOVA and MANCOVA procedures were applied.
Extension of Conventional Multivarlate Statistical
WecontrastedthefindingsfromSSMwiththoseobtainedusing
conventional multivariatestatistical techniques. Since SSM was
designedto reveal independentsets oftopographic patternsandto
score individuals for the degree to which they manifested these
networks, we developed methods that allow derivation of similar
measures using a conventional multivariate approach. A MAN
COVA (grouped by sex, with age and PCO2 as covaiiates) was
conductedon theCBFvaluesatthe32detectors.Theaimwasto
establish a significantgroup by region interaction, thereby con
firmingthat the groups differed in topographiceffects. Based on
thecharacteristicvectors(72),thedescriptivediscniminantfunc
tions that characterized this interaction were computed. These
linear functions produce optimal weights for each brain region,
maximizing separation of the groups in their overall means on the
functions, i.e., the average topographywithin a group (71). Sub
jectscoreswerederivedforeachdiscriminantfunction,quantify
ingthe extent to whicheach subjectmanifestedeach topographic
pattern. These subject scores were computed by multiplyingthe
raw values at each brainregionby the correspondingregion
weight and summing across regions. Once these subject scores
were derived, Pearson product-momentcorrelations were com
putedacrossthe samplebetweenthe rawvaluesat eachregion
and each subject's score on the respective discniminantfunction.
Thesecorrelationsquantifiedof the importanceof individualre
gions to the group separation in topography. Such correlations,
termed structurecoefficients, are thought to be more stable than
theoriginalregionalweightsin thedescriptivediscriminantfunc
tions (71,73). Standardsignificancetests of the correlations(struc
ture coefficients) identifiedthe sets of brain regions that defined
thetopographicpatternsthatdistinguishedthegroups.
This application of a conventional multivariate approach was
applied twice, using either the raw rCBF values at each detector
or the raw values normalized by each subject's glObal mean (i.e.,
ratio scores) as dependent measures. Only the results using ratio
scores are reported. The findings using the raw values were
deemedlesssatisfactoryfortworeasons.First,as inourprevious
study (47), in the analysis of raw values, the linear discriminant
functionsthatcharacterizedthe topographiesthatdistinguished
thegroupswerehighlycontaminatedby thegroupdifferencesin
global CBF. This suppressed the topographic abnormalities in the
clinicalgroups by saturating the structure coefficientswith the
glObaldifferences in CBF. Second, SSM's detailing of topography
was based on analysisof normalizedvalues (SRPs). Conse
quently, submitting ratio scores to the conventional statistical
approach allowed for more even-handed comparison with SSM.




of 41 depressedpatientsand40 controls(47).Thesampleexam
inedhereincluded60of theprevioussubjects(30depressedand
30 controls) and 30 new patients with Alzheimer's disease. The
stability of each method's detailing of topographic patterns and
subject scores for these patterns was evaluated by testing reprod
ucabiityin thesubjectscommonto bothstudies.ForSSM,cor
relation coefficients were computed between the regions loading
on comparableGISsandforcomparableSSFs. Fortheconven
tional approach, similar correlations were performed on the struc
ture coefficients (after z-transformation) and on the subject scores
on thediscriminantfunctions.
Validity was assessed in several ways. The conventional ap
proach yielded fewer topographic structures than SSM. To deter
mine whether the topographies reflected in the discniminant func
tions were an amalgam of the more discrete SSM patterns,
multipleregressionanalyseswereconductedpredictingthe sub
ject discniminant function on scores on the basis of the SSFs.
WithintheAlzheimer'sample,multipleregressionanalyseswere
also used to examinethe relationsbetweenclinicalindicesof
diseaseseverityandeachmethod'sscoringof individualdiffer





explore utility for differential diagnosis, the parameters derived
withbothapproacheswere submittedto predictivediscriminant
classification analyses, using the topographic and global values to
classifysubjectsinto the three diagnosticgroups. In these classi
fication analyses, the prior probabilities reflected the sample size
of each group, i.e., each group comprised 33.3%of all subjects.
Throughout, ANCOVAs and MANCOVAS were performed using
diagnostic group and sex as between-subject terms and age and
â€˜@02 as covariates. The significance of multivaniate effects was
assessed with the F-test associated with Wilks' A.All effects were
evaluated with two-tailed tests of significance.
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Izheimer's disease (AD) and late
- e depression (LLD) are usually
thoughtof as discrete braindisorders.
Unfortunately, as with many clinical
syndromes, there can be considerable
overlap in their presentation. Depres
sive disorders occur in 1O%â€”20%of
patients with AD (1), and some pa
tients with LW have cognitive defi
cits that reach clinically meaningful
proportions (2) and may resolve with
effective treatment of the underlying
mood disorder (3). It is not surprising
then that clinical diagnoses are not al
ways reliable. One reviewer noted
that 8% of British patients who were
initially diagnosed with dementia were
subsequently determined to have ma
jor depression (4).
For planninga therapeuticregimen,
an accurate diagnostic assessment is
critical. LLD is responsive to both an
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tidepressant medication and electro
convulsive therapy (ECF) (5). How
ever, medication side effects are
common in the elderly, who often
have comorbid medical conditions,
and medication-inducedcognitive de
clime is especially likely in patients
with dementia. ECF also generally
worsens cognitive deficits, at least
acutely, in all patients (6). A range of
different treatment strategies has been
proposed for patients with AD and
several promisingnew agents are now
being assessed in clinical trials (7).
These medications also have side ef
fects and theirbenefits are unlikely to
be shared by patients with LU).
Although progress in defining the
pathophysiology of psychiatric disor
ders in the elderly has been slow, the
available evidence clearly suggests
that both LLD and AD are associated
with derangements in brain structure
and function. Structuralbrainimaging
studies have shown that both disor
ders are associated with increased
ratesof cerebralinfarction,cortical at
rophy and leukoencephalopathy (8).
Similarly, functional brain imaging
studies suggest that global cortical
blood flow is decreased to a similar
degree in patients with LLD or AD
(9,10). Therefore, the development of
brain imaging techniques with diag
nostic utility for LU) andAD is likely
to depend upon an assessment of al
terations in regional brainmetabolism
either at rest or in response to phar
macologic challenge or neuropsycho
logic tasks.
In this issue of the Journal, Sack
eim et al. (11) report an analysis of
patterns of regional cerebral blood
flow, determinedusing the â€˜33Xejulia
lation technique, in large groups of
well-matched patients with LU) and
AD. A Scaled Subprofile Model
(SSM), which was initially developed
to identify abnormal functional net
works in clinical brain images (12),
was used to distinguishpatient groups
according to distinct topographic pro
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